NCT00078754View on ClinicalTrials.gov

A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Intermittent Explosive Disorder
Interventions
DRUG

Fluoxetine

Fluoxetine capsules by mouth, up to 60 mg daily

DRUG

Divalproex

Divalproex ER capsules by mouth, up to 3000 mg daily

DRUG

Placebo

Placebo capsules by mouth, up to 8 capsules daily

Trial Locations (1)

60637

The University of Chicago, Chicago

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Chicago

OTHER

NCT00078754 - A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder | Biotech Hunter | Biotech Hunter